DAVITA INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
DAVITA INC. (DVA) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $4.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-11
- DAVITA INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $4.80M, a 42.20% decline from fiscal 2024.
- DAVITA INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $8.31M, a 53.08% increase from fiscal 2023.
- DAVITA INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $5.43M, a 10.62% decline from fiscal 2022.
- DAVITA INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $6.07M, a 708.66% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2025-12-31 | $4.80M 10-K · filed 2026-02-11 |
| 2024-12-31 | $8.31M 10-K · filed 2026-02-11 |
| 2023-12-31 | $5.43M 10-K · filed 2025-02-13 |
| 2022-12-31 | $6.07M 10-K · filed 2024-02-14 |
| 2021-12-31 | $751.00K 10-K · filed 2023-02-22 |
| 2020-12-31 | $133.00K 10-K · filed 2022-02-11 |
| 2019-12-31 | $268.00K 10-K · filed 2021-02-12 |
| 2018-12-31 | $338.00K 10-K · filed 2020-02-21 |
| 2017-12-31 | $1.38M 10-K · filed 2019-02-22 |
| 2016-12-31 | $1.28M 10-K · filed 2018-02-23 |
| 2015-12-31 | $2.00M 10-K · filed 2017-02-24 |
| 2014-12-31 | $2.08M 10-K · filed 2016-02-26 |
| 2013-12-31 | $8.48M 10-K · filed 2015-02-26 |
| 2012-12-31 | $1.94M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |